“…Of all patients who underwent salvage radiotherapy, 4/21 (19%) patients in the RS-RARP group and 8/21 (38%) patients in the SA-RARP group had a combination of ISUP 4-5 + pT3 + R1 disease ( p = 0.17). Median follow-up in the SA-RARP and RS-RARP groups was 24.5 [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ] vs. 22 [ 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ] months, respectively ( p = 0.008).…”